Search research articles
Contact Us
Filters
Showing results (711-720 of 839) with videos related to
Page
of 84
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer
Lorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
JAMA Oncology
|
June 4, 2026
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis
Alessandro Di Federico, Samuele Compagno, Francesco Mantuano, et al.
JAMA Oncology
|
May 23, 2024
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
Tafadzwa L Chaunzwa, Jack M Qian, Qin Li, et al.
British Journal of Pharmacology
|
December 17, 2013
Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo
N Fakhrudin, B Waltenberger, M Cabaravdic, et al.
Plos One
|
October 17, 2013
Imbricaric acid and perlatolic acid: multi-targeting anti-inflammatory depsides from Cetrelia monachorum
Sarah K Oettl, Jana Gerstmeier, Shafaat Y Khan, et al.
JCO Precision Oncology
|
October 5, 2020
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis
Yi Lee, Evan W Clark, Marina S D Milan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2013
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer
Justin F Gainor, Anna M Varghese, Sai-Hong Ignatius Ou, et al.
Science Immunology
|
May 20, 2022
<i>Clostridium septicum</i> α-toxin activates the NLRP3 inflammasome by engaging GPI-anchored proteins
Weidong Jing, Jordan Lo Pilato, Callum Kay, et al.
Nature Cancer
|
January 8, 2026
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Mariano Provencio, Mark M Awad, Jonathan D Spicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Mark M Awad, Patrick M Forde, Nicolas Girard, et al.
Page
of 84
Search research articles
Search
Showing results (711-720 of 839) with videos related to
Sort By:
Page
of 84
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer
Lorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
JAMA Oncology
|
June 4, 2026
PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression: A Systematic Review and Meta-Analysis
Alessandro Di Federico, Samuele Compagno, Francesco Mantuano, et al.
JAMA Oncology
|
May 23, 2024
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
Tafadzwa L Chaunzwa, Jack M Qian, Qin Li, et al.
British Journal of Pharmacology
|
December 17, 2013
Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo
N Fakhrudin, B Waltenberger, M Cabaravdic, et al.
Plos One
|
October 17, 2013
Imbricaric acid and perlatolic acid: multi-targeting anti-inflammatory depsides from Cetrelia monachorum
Sarah K Oettl, Jana Gerstmeier, Shafaat Y Khan, et al.
JCO Precision Oncology
|
October 5, 2020
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis
Yi Lee, Evan W Clark, Marina S D Milan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2013
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer
Justin F Gainor, Anna M Varghese, Sai-Hong Ignatius Ou, et al.
Science Immunology
|
May 20, 2022
<i>Clostridium septicum</i> α-toxin activates the NLRP3 inflammasome by engaging GPI-anchored proteins
Weidong Jing, Jordan Lo Pilato, Callum Kay, et al.
Nature Cancer
|
January 8, 2026
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Mariano Provencio, Mark M Awad, Jonathan D Spicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Mark M Awad, Patrick M Forde, Nicolas Girard, et al.
Page
of 84